Besides, Hung et al. reported that tyrosine-protein kinase receptor TYRO3 (TYRO3) overexpression elicited anti-PD-1/PD-L1 resistance through protecting tumor cells from immunotherapy-induced ferroptosis [51]. The gene discussed is PDCD1; the disease is neoplasm.